Nurse Edition Latest Issue TOC

Article

Healthcare providers are long overdue for some in-depth help when it comes to talking with patients and families during times of personal tragedy.

FROM THE EDITOR

Back to Basics: Communication 101Deborah A. Boyle, RN, MSN, AOCNS, FAAN

Healthcare providers are long overdue for some in-depth help when it comes to talking with patients and families during times of personal tragedy.

COVER STORY

Metastatic Colorectal Cancer: Management Challenges and Opportunities


Gail M. Wilkes, MS, APRN-BC, AOCN

CME
Advances in the multidisciplinary management of metastatic colorectal cancer have improved survival considerably, and nurses are key to optimal patient care.

• Article Reviewed: The Evolving Care of Metastatic Colorectal Cancer

INTEGRATIVE ONCOLOGY

Acupuncture in Cancer Care


Gary Deng, MD, PhD, Barrie Cassileth, PhD

Acupuncture is a therapeutic modality in Traditional Chinese Medicine (TCM), developed over the millennia. Treatment involves the placement of needles at selected points on the body, followed by manipulation with physical forces, heat, or, in modern times, electrical stimuli.

DRUG ESSENTIALS

Ipilimumab, a Human Monoclonal Antibody for Treatment of Unresectable or Metastatic Melanoma


Gail M. Wilkes, MS, APRN-BC, AOCN

Ipilimumab is a human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen 4 (CTLA-4). CTLA-4 normally turns off activation of the powerful cytotoxic T cells, which are able to kill cancer cells.

CASE STUDY

Invasive Aspergillosis in an Allogeneic Hematopoietic Cell Transplant Patient


Laura Zitella, RN, MS, ACNP, AOCN

Invasive aspergillosis is a major cause of life-threatening infection in immunocompromised patients. Nurses are well positioned to identify, educate, and monitor patients at high risk.

ONLINE EXCLUSIVES
Polypharmacy in Older Adult Cancer PatientsDeborah A. Boyle, RN, MSN, AOCNS, FAAN

Older patients may fail to consume their medications as prescribed because of faulty memory, a lack of understanding about the treatments they are being given and their importance, or concerns about cost.

 

• The Older Cancer Patient

: Resources for Care

• News of Note

: Literature Highlights

Recent Videos
Brett L. Ecker, MD, discusses the importance of multidisciplinary collaboration in improving patient outcomes in neuroendocrine tumors.
2 experts are featured in this series.
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Related Content
A computational linguistics model designed to locate pancreatic cysts that started to locate pancreatic cancer has the potential to lead to more efficient treatment.

AI Software Learns to Identify Pancreatic Cancer Vs Cysts

Russell C. Langan, MD
November 26th 2024
Article

A computational linguistics model designed to locate pancreatic cysts that started to locate pancreatic cancer has the potential to lead to more efficient treatment.

Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.

Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer

Tanios S. Bekaii-Saab, MD, FACP
November 25th 2024
Podcast

Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.

For patients with KRAS-mutated colorectal cancer, onvansertib plus FOLFIRI/bevacizumab was effective in those who had not received prior bevacizumab.

Onvansertib Combo Shows Significant Efficacy in KRAS+ Colorectal Cancer

Tim Cortese
November 26th 2024
Article

For patients with KRAS-mutated colorectal cancer, onvansertib plus FOLFIRI/bevacizumab was effective in those who had not received prior bevacizumab.

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

Collaboration Fosters Treatment Advancements for Young Lymphoma Populations

Andrew M. Evens, DO, MS
November 18th 2024
Podcast

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

A computational linguistics model has mitigated disparities in surveillance of the pancreas that primarily affected racial and ethnic minorities.

Bridging Racial and Ethnic Minority Disparities in Pancreatic Cyst Surveillance

Russell C. Langan, MD
November 25th 2024
Article

A computational linguistics model has mitigated disparities in surveillance of the pancreas that primarily affected racial and ethnic minorities.

Site Logo

SPM AE Incidence After CAR T-Cell Therapy in Lymphoma and Myeloma

American Society for Transplantation and Cellular Therapy
November 25th 2024
Article

Findings from the Phase 3 AURIGA trial support the use of lenalidomide plus daratumumab vs lenalidomide alone as post-transplant maintenance therapy for patients with newly diagnosed multiple myeloma.